Ayodeji Adegunsoye to Lung Diseases, Interstitial
This is a "connection" page, showing publications Ayodeji Adegunsoye has written about Lung Diseases, Interstitial.
Connection Strength
12.951
-
Tobacco smoking is associated with combined pulmonary fibrosis and emphysema and worse outcomes in interstitial lung disease. Am J Physiol Lung Cell Mol Physiol. 2023 08 01; 325(2):L233-L243.
Score: 0.725
-
Interstitial lung disease: a decade of progress and hope. Lancet Respir Med. 2023 06; 11(6):510-512.
Score: 0.721
-
Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis. Immunol Allergy Clin North Am. 2023 05; 43(2):209-228.
Score: 0.709
-
Inhaled Nitric Oxide for Fibrotic Interstitial Lung Disease: A Step Forward. Ann Am Thorac Soc. 2022 04; 19(4):536-538.
Score: 0.665
-
High-titer rheumatoid factor seropositivity predicts mediastinal lymphadenopathy and mortality in rheumatoid arthritis-related interstitial lung disease. Sci Rep. 2021 11 24; 11(1):22821.
Score: 0.649
-
The Progression to Interstitial Lung Disease: Vicarious Facts About Visceral Fat. Chest. 2021 08; 160(2):400-402.
Score: 0.635
-
Diagnostic Classification of Interstitial Lung Disease in Clinical Practice. Clin Chest Med. 2021 06; 42(2):251-261.
Score: 0.628
-
CPAP Adherence, Mortality, and Progression-Free Survival in Interstitial Lung Disease and OSA. Chest. 2020 10; 158(4):1701-1712.
Score: 0.585
-
Computed Tomography Honeycombing Identifies a Progressive Fibrotic Phenotype with Increased Mortality across Diverse Interstitial Lung Diseases. Ann Am Thorac Soc. 2019 05; 16(5):580-588.
Score: 0.543
-
Reply to Lescoat et al. and to Khamis et al. Am J Respir Crit Care Med. 2019 04 15; 199(8):1041-1042.
Score: 0.542
-
Prognosticating Outcomes in Interstitial Lung Disease by Mediastinal Lymph Node Assessment. An Observational Cohort Study with Independent Validation. Am J Respir Crit Care Med. 2019 03 15; 199(6):747-759.
Score: 0.538
-
Integrating Genomics Into Management of Fibrotic Interstitial Lung Disease. Chest. 2019 05; 155(5):1026-1040.
Score: 0.533
-
African-American race and mortality in interstitial lung disease: a multicentre propensity-matched analysis. Eur Respir J. 2018 06; 51(6).
Score: 0.511
-
Phenotypic Clusters Predict Outcomes in a Longitudinal Interstitial Lung Disease Cohort. Chest. 2018 02; 153(2):349-360.
Score: 0.487
-
Therapeutic Approach to Adult Fibrotic Lung Diseases. Chest. 2016 Dec; 150(6):1371-1386.
Score: 0.450
-
Predictors of survival in coexistent hypersensitivity pneumonitis with autoimmune features. Respir Med. 2016 05; 114:53-60.
Score: 0.438
-
Reply: Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung disease. Eur Respir J. 2024 Jan; 63(1).
Score: 0.188
-
Treatment of Systemic Sclerosis-associated Interstitial Lung Disease: Evidence-based Recommendations. An Official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2024 Jan 15; 209(2):137-152.
Score: 0.188
-
Telomere length and immunosuppression in non-idiopathic pulmonary fibrosis interstitial lung disease. Eur Respir J. 2023 11; 62(5).
Score: 0.187
-
A Deep Learning-Based Radiomic Classifier for Usual Interstitial Pneumonia. Chest. 2024 Feb; 165(2):371-380.
Score: 0.185
-
Sex- and Race-Based Differences in the Treatment of Interstitial Lung Diseases in North America and Australasia. Chest. 2023 05; 163(5):1156-1165.
Score: 0.175
-
Validation of Proposed Criteria for Progressive Pulmonary Fibrosis. Am J Respir Crit Care Med. 2023 01 01; 207(1):69-76.
Score: 0.175
-
Updated Imaging Classification of Hypersensitivity Pneumonitis. Radiol Clin North Am. 2022 Nov; 60(6):901-913.
Score: 0.171
-
MUC5B, telomere length and longitudinal quantitative interstitial lung changes: the MESA Lung Study. Thorax. 2023 06; 78(6):566-573.
Score: 0.170
-
Integration and Application of Clinical Practice Guidelines for the Diagnosis of Idiopathic Pulmonary Fibrosis and Fibrotic Hypersensitivity Pneumonitis. Chest. 2022 Sep; 162(3):614-629.
Score: 0.169
-
Lung function trajectory in progressive fibrosing interstitial lung disease. Eur Respir J. 2022 06; 59(6).
Score: 0.169
-
Inhalational exposures in patients with fibrotic interstitial lung disease: Presentation, pulmonary function and survival in the Canadian Registry for Pulmonary Fibrosis. Respirology. 2022 08; 27(8):635-644.
Score: 0.167
-
Screening Strategies for Pulmonary Hypertension in Patients With Interstitial Lung Disease: A Multidisciplinary Delphi Study. Chest. 2022 07; 162(1):145-155.
Score: 0.165
-
Treatment of fibrotic interstitial lung disease: current approaches and future directions. Lancet. 2021 10 16; 398(10309):1450-1460.
Score: 0.160
-
Vessel-related structures predict UIP pathology in those with a non-IPF pattern on CT. Eur Radiol. 2021 Oct; 31(10):7295-7302.
Score: 0.155
-
Characteristics and Prevalence of Domestic and Occupational Inhalational Exposures Across Interstitial Lung Diseases. Chest. 2021 07; 160(1):209-218.
Score: 0.154
-
Circulating Plasma Biomarkers of Progressive Interstitial Lung Disease. Am J Respir Crit Care Med. 2020 01 15; 201(2):250-253.
Score: 0.143
-
Diagnostic test interpretation and referral delay in patients with interstitial lung disease. Respir Res. 2019 Nov 12; 20(1):253.
Score: 0.141
-
Telomere length and genetic variant associations with interstitial lung disease progression and survival. Eur Respir J. 2019 04; 53(4).
Score: 0.135
-
Underreporting of Interstitial Lung Abnormalities on Lung Cancer Screening Computed Tomography. Ann Am Thorac Soc. 2018 06; 15(6):764-766.
Score: 0.127
-
CT Features of the Usual Interstitial Pneumonia Pattern: Differentiating Connective Tissue Disease-Associated Interstitial Lung Disease From Idiopathic Pulmonary Fibrosis. AJR Am J Roentgenol. 2018 Feb; 210(2):307-313.
Score: 0.123
-
CT Findings, Radiologic-Pathologic Correlation, and Imaging Predictors of Survival for Patients With Interstitial Pneumonia With Autoimmune Features. AJR Am J Roentgenol. 2017 Jun; 208(6):1229-1236.
Score: 0.117
-
A call for uniformity in implementing the IPAF (interstitial pneumonia with autoimmune features) criteria. Eur Respir J. 2016 12; 48(6):1813-1814.
Score: 0.115
-
Azathioprine response in patients with fibrotic connective tissue disease-associated interstitial lung disease. Respir Med. 2016 12; 121:117-122.
Score: 0.114